ConductScience.org, home

Paper38020309

Inhibition of cancer cell‑platelet adhesion as a promising therapeutic target for preventing peritoneal dissemination of gastric cancer.

Nakayama T and 18 others. Oncol Lett, 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Inhibition of cancer cell‑platelet adhesion as a promising therapeutic target for preventing peritoneal dissemination of gastric cancer. Papers, record 38020309. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38020309

Download JSON
Cell line
MKN7451 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of cancer cell‑platelet adhesion as a promising therapeutic target for preventing peritoneal dissemination of gastric cancer.
PubMed
Journal
Oncol Lett
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.67
iCite
Revised in PubMed
2023-12-01
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nakayama TTakashi
2Saito RRyo
3Furuya SShinji
4Shoda KKatsutoshi
5Maruyma SSuguru
6Takiguchi KKoichi
7Shiraishi KKensuke
8Akaike HHidenori
9Kawaguchi YYoshihiko
10Amemiya HHidetake
11Kawaida HHiromichi
12Tsukiji NNagaharu
13Shirai TToshiaki
14Shinmori HHideyuki
15Yamamoto MMasami
16Nomura SSachiyo
17Tsukamoto TTetsuya
18Suzuki-Inoue KKatsue
19Ichikawa DDaisuke

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119308640Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer.World J Surg2009https://conductscience.org/library/papers/19308640PubMed
225201501Increase in peritoneal recurrence induced by intraoperative hemorrhage in gastrectomy.Ann Surg Oncol2015https://conductscience.org/library/papers/25201501PubMed
317635696Platelet integrin alpha(IIb)beta(3): activation mechanisms.J Thromb Haemost2007https://conductscience.org/library/papers/17635696PubMed
432393895The claustrum coordinates cortical slow-wave activity.Nat Neurosci2020https://conductscience.org/library/papers/32393895PubMed
522119323Expression of galectin-3 in mouse endometrium and its effect during embryo implantation.Reprod Biomed Online2012https://conductscience.org/library/papers/22119323PubMed
632724431Extravasated platelet aggregation contributes to tumor progression via the accumulation of myeloid-derived suppressor cells in gastric cancer with peritoneal metastasis.Oncol Lett2020https://conductscience.org/library/papers/32724431PubMed
711846609Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods2001https://conductscience.org/library/papers/11846609PubMed
82808700A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion.J Clin Invest1989https://conductscience.org/library/papers/2808700PubMed
93580576A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia.Blood1987https://conductscience.org/library/papers/3580576PubMed
1035847435Gastric and gastroesophageal junction cancer: Risk factors and prophylactic treatments for prevention of peritoneal recurrence after curative intent surgery.Ann Gastroenterol Surg2022https://conductscience.org/library/papers/35847435PubMed
1131570451Impact of Extravasated Platelet Activation and Podoplanin-positive Cancer-associated Fibroblasts in Pancreatic Cancer Stroma.Anticancer Res2019https://conductscience.org/library/papers/31570451PubMed
1231778548Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.Blood2019https://conductscience.org/library/papers/31778548PubMed
1333420680Hippocampal Degeneration and Behavioral Impairment During Alzheimer-Like Pathogenesis Involves Glutamate Excitotoxicity.J Mol Neurosci2021https://conductscience.org/library/papers/33420680PubMed
1422992842The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis.J Biochem2012https://conductscience.org/library/papers/22992842PubMed
1512730118Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: involvement of PLCgamma1 and PI3-kinase.Blood2003https://conductscience.org/library/papers/12730118PubMed
1622041285Effect of three types of mixed anesthetic agents alternate to ketamine in mice.Exp Anim2011https://conductscience.org/library/papers/22041285PubMed
1729863151Treatment of patients with peritoneal metastases from gastric cancer.Ann Gastroenterol Surg2018https://conductscience.org/library/papers/29863151PubMed
1822728022Platelet aggregometry in the presence of PGE(1) provides a reliable method for cilostazol monitoring.Thromb Res2012https://conductscience.org/library/papers/22728022PubMed
1930190281Cobalt hematoporphyrin inhibits CLEC-2-podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice.Blood Adv2018https://conductscience.org/library/papers/30190281PubMed
2030845955Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting.J Hematol Oncol2019https://conductscience.org/library/papers/30845955PubMed

See all 39 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41105878TGFβ enhances platelet-breast-cancer-cell interaction and promotes platelet aggregation.FEBS J2026https://conductscience.org/library/papers/41105878PubMed
40457079Targeting platelet-tumor cell interactions: a novel approach to cancer therapy.Med Oncol2025https://conductscience.org/library/papers/40457079PubMed
39370518Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication.J Nanobiotechnology2024https://conductscience.org/library/papers/39370518PubMed
39211304Molecular mechanisms driving the interactions between platelet and gastric cancer cells during peritoneal dissemination.Oncol Lett2024https://conductscience.org/library/papers/39211304PubMed
38881709Establishment of a novel small bowel adenocarcinoma cell line using patient‑derived xenografts, which produces CEA and CA19‑9.Oncol Lett2024https://conductscience.org/library/papers/38881709PubMed
38250681Surgery with minimal bleeding.Ann Gastroenterol Surg2024https://conductscience.org/library/papers/38250681PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38020309

GET https://conductscience.org/api/papers/v1/38020309/references?page=2